Tag:
Entelos
Latest Headlines
Latest Headlines
Entelos stages comeback bid with funding
Back out of bankruptcy, modeling and simulation software company Entelos has recapitalized its business and brought on a new investor, the San Mateo, CA-based company said last week. The company,
FDA adopts simulation tech
The FDA will deploy new computer technology from Entelos to simulate the activity of experimental medications so the agency can get an earlier read on the safety and efficacy of drugs in the
FDA will use computer tech to guide trial design
The FDA will deploy new computer technology from Entelos to simulate the activity of experimental medications so the agency can get an earlier read on the safety and efficacy of drugs in the
Entelos inks deal with Lilly
Shares of the UK's Entelos surged after the company reported a licensing pact with Eli Lilly. The pact covers access to Entelos' database of 630 drug profiles, which is used to test an experimental
ALSO NOTED: MonoSol Rx sets IPO; Entelos buys Iconix; and much more...
> MonoSol Rx has set the terms on an IPO of four million shares. The offering is expected to raise up to $70 million if its hits its range of $16 to $18 a share.
ALSO NOTED: Integra buys IsoTis for $49.3M; MannKind searches for insulin drug partner; and much more...
> Device maker Integra LifeSciences is buying IsoTis for $49.3 million.
